Shares of Hinge Health Inc. (NYSE:HNGE - Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $44.14, but opened at $47.00. Hinge Health shares last traded at $46.31, with a volume of 420,511 shares trading hands.
Analysts Set New Price Targets
HNGE has been the topic of a number of recent research reports. Wall Street Zen raised shares of Hinge Health to a "hold" rating in a research report on Monday, June 2nd. Citizens Jmp initiated coverage on shares of Hinge Health in a report on Monday. They set a "mkt outperform" rating and a $58.00 target price on the stock. Barclays boosted their price target on Hinge Health from $43.00 to $51.00 and gave the company an "overweight" rating in a research note on Monday. Raymond James Financial assumed coverage on Hinge Health in a report on Monday, June 16th. They issued an "outperform" rating and a $45.00 price objective for the company. Finally, JMP Securities initiated coverage on Hinge Health in a report on Monday. They set a "market outperform" rating and a $58.00 target price on the stock. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $49.36.
Get Our Latest Stock Report on Hinge Health
Hinge Health Stock Performance
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Read More
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
